文献速递临床试验与 GCP真实世界研究与卫生经济

通过支持性就业与教育(SEEearly)促进早期精神病青少年和年轻成人教育与职业康复:多中心随机对照试验研究方案

Enhancing educational and vocational recovery in adolescents and young adults with early psychosis through Supported Employment and Education (SEEearly): study protocol for a multicenter randomized controlled trial.
PubMed 文献 · Trials · 2023-07-03

SEEearly试验是一项六中心、双臂、单盲、优效性随机对照试验,比较门诊精神科常规治疗(TAU)联合支持性就业与教育(SEE)与单用TAU对早期精神病患者的效果。计划招募184例16至35岁患者,主要结局为12个月随访期间至少50%时间稳定参与竞争性就业和/或主流教育。研究假设TAU联合SEE组的主要和次要结局优于单用TAU组。

要点

  • SEEearly在门诊精神科环境中比较TAU联合SEE与单用TAU对早期精神病患者就业与教育康复的效果。
  • 主要结局为12个月随访期间至少50%时间稳定参与竞争性就业和/或主流教育。
  • 计划招募184例16至35岁符合早期精神病诊断标准且有意愿参与竞争性就业和/或主流教育的患者。

核心结论

  • 研究假设接受TAU联合SEE的早期精神病患者的主要和次要结局优于单用TAU的患者;若结果阳性,将证明SEE可作为早期精神病患者临床常规治疗的循证策略。

研究设计与样本

  • 六中心、双臂、单盲、优效性随机对照试验,在门诊精神科环境中比较TAU联合SEE与单用TAU,按1:1随机分配。
  • 计划招募184例参与者,假设脱落率22%,以90%把握度检测主要结局(就业/教育)24%的差异。
  • 评估时间点为基线、6个月和12个月随访;就业/教育、药物和当前精神科治疗数据通过每月电话简短评估获取。
  • 纳入标准:年龄16至35岁,符合早期精神病诊断标准,且有意愿参与竞争性就业和/或主流教育。

关键数值与推荐

  • 主要结局为12个月随访期间至少50%时间稳定参与竞争性就业和/或主流教育。
  • 次要就业结局包括就业/教育时长、首次就业/教育时间、月工资/教育成就和社会投资回报(SROI)。
  • 次要非就业结局包括主观生活质量、精神病理学、物质使用、复发、住院和功能损害。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psychotic disorders often develop a chronic course with devastating consequences for individuals, families, and societies. Early intervention programs for people in the first 5 years after the initial psychotic episode (early psychosis) can significantly improve the outcome and are therefore strongly recommended in national and international guidelines. However, most early intervention programs still focus on improving symptoms and relapse prevention, rather than targeting educational and vocational recovery. The aim of the present study is to explore the effects of Supported Employment and Education (SEE) following the Individual Placement and Support (IPS) model in people with early psychosis. METHODS: The SEEearly trial compares treatment as usual (TAU) plus SEE to TAU alone in outpatient psychiatric settings. The study is a six-site, two-arm, single-blinded, superiority randomized controlled trial (RCT). Participants are randomly assigned (1:1) to the intervention or control group. Aiming to recruit 184 participants, with an assumed drop-out rate of 22%, we will be able to detect a 24% difference in the main outcome of employment/education with 90% power. We make assessments at baseline and at 6- and 12-month follow-ups. Outcome data on employment/education, medication, and current psychiatric treatment is obtained monthly through phone based short assessments. The primary outcome is steady participation for at least 50% of the 12-month follow-up in competitive employment and/or mainstream education. Secondary employment outcomes capture length of employment/education, time to first employment/education, monthly wages/educational attainment, and social return on investment (SROI). Secondary non-employment outcomes include subjective quality of life, psychopathology, substance use, relapse, hospitalization, and functional impairment. To be eligible, participants must be between 16 and 35 years, fulfill diagnostic criteria for early psychosis, and be interested in competitive employment and/or mainstream education. DISCUSSION: In SEEearly, we hypothesize that participants with psychosis, who receive TAU plus SEE, present with better primary and secondary outcomes than participants, who receive TAU alone. Positive results of this study will justify SEE as an evidence-based strategy for clinical routine treatment in people with early psychosis. TRIAL REGISTRATION: SEEearly was registered nationally and internationally in the German Clinical Trials Register (DRKS; identifier: DRKS00029660) on October 14, 2022.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jäckel D, Willert A, Brose A, et al. Enhancing educational and vocational recovery in adolescents and young adults with early psychosis through Supported Employment and Education (SEEearly): study protocol for a multicenter randomized controlled trial. Trials. 2023. PMID: 37400899. doi:10.1186/s13063-023-07462-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。